المؤلفون: Gebbia V; Casa di Cura Torina, Palermo, Italy.; Faculty of Medicine and Surgery, Kore University, Enna, Italy., Martorana F; Medical Oncology Unit, Humanitas Istituto Clinico Catanese, Catania, Italy.; Department of Clinical and Experimental Medicine, Center of Experimental Oncology and Hematology, University of Catania, Catania, Italy., Scandurra G; Medical Oncology, Ospedale Cannizzaro, Catania, Italy., Valerio MR; Medical Oncology, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy., Cufari S; Pharmacist Private Practice, Messina, Italy., Vigneri P; Medical Oncology Unit, Humanitas Istituto Clinico Catanese, Catania, Italy.; Department of Clinical and Experimental Medicine, Center of Experimental Oncology and Hematology, University of Catania, Catania, Italy., Sanò MV; Medical Oncology Unit, Humanitas Istituto Clinico Catanese, Catania, Italy., Scollo P; Faculty of Medicine and Surgery, Kore University, Enna, Italy.; Gynecological Oncology Unit, Ospedale Cannizzaro, Catania, Italy.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Jul; Vol. 30 (5), pp. 853-859. Date of Electronic Publication: 2023 Jul 27.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Cyclophosphamide*/administration & dosage , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/adverse effects , Administration, Metronomic* , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/pathology , Antineoplastic Agents, Alkylating*/administration & dosage , Antineoplastic Agents, Alkylating*/therapeutic use , Antineoplastic Agents, Alkylating*/adverse effects, Humans ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Italy ; Adult ; Aged, 80 and over ; Administration, Oral ; Carcinoma, Ovarian Epithelial/drug therapy ; Treatment Outcome ; Neoplasm Recurrence, Local/drug therapy

المؤلفون: Giordano G; Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Milella M; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Landriscina M; Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Bergamo F; Department of Oncology, Veneto Institute of Oncology IRCCS, Padova, Italy., Tirino G; Unit of Medical Oncology, Sacro Cuore di Gesu'-Fatebenefratelli Hospital, Benevento, Italy., Santaniello A; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Zaniboni A; Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy., Vasile E; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., De Vita F; Division of Medical Oncology, Department of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy., Re GL; Medical Oncology and Immune-Related Tumors, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Vaccaro V; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Giommoni E; Medical Oncology Unit, Careggi University Hospital, Florence, Italy., Natale D; Ospedale San Massimo, Penne, Italy., Conca R; Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy., Santini D; Medical Oncology A, University of Rome, Policlinico Umberto I, 'La Sapienza, Rome, Italy., Maiorino L; Medical Oncology Unit, San Gennaro Hospital, Naples, Italy., Sanna G; Medical Oncology, Istituto Ospedaliero dell'Università di Sassari, Sassari, Italy., Ricci V; Medical Oncology Unit, Azienda Ospedaliera di Rilievo Nazionale 'San Pio', Benevento, Italy., Iop A; Department of Oncology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy., Montesarchio V; Oncology Unit-A.O.R.N. dei Colli, Monaldi Hospital, Naples, Italy., Procaccio L; Department of Oncology, Veneto Institute of Oncology IRCCS, Padova, Italy., Noventa S; Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy., Bianco R; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Febbraro A; Unit of Medical Oncology, Sacro Cuore di Gesu'-Fatebenefratelli Hospital, Benevento, Italy., Lonardi S; Department of Oncology, Veneto Institute of Oncology IRCCS, Padova, Italy., Tortora G; Oncologia Medica, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy.; Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy., Sperduti I; Biostatistical Unit, IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri, Rome, Italy., Melisi D; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.; Investigational Cancer Therapeutics Clinical Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.; Digestive Molecular Clinical Oncology Research Unit, University of Verona, Verona, Italy.

المصدر: Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (12), pp. e7345.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/pathology , Pancreatic Neoplasms*/mortality , Gemcitabine* , Deoxycytidine*/analogs & derivatives , Deoxycytidine*/administration & dosage , Deoxycytidine*/therapeutic use , Albumins*/administration & dosage , Albumins*/therapeutic use , Albumins*/adverse effects , Paclitaxel*/administration & dosage , Paclitaxel*/therapeutic use , Paclitaxel*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Prognosis ; Adult ; Aged, 80 and over ; Treatment Outcome ; Italy ; Neoplasm Metastasis

عنوان ترانسليتريتد: Position paper della Società Italiana di Cardiologia Pediatrica (SICP) su prevenzione, diagnosi, trattamento e follow-up della cardiotossicità nei pazienti oncologici pediatrici.

المؤلفون: Bennati E; Azienda Ospedaliera Meyer IRCCS, Firenze., Castaldi B; Azienda Ospedale-Università di Padova., Derchi ME; IRCCS, Istituto Giannina Gaslini, Genova., Spoto S; ARNAS Civico Di Cristina Benfratelli, Palermo., Chinali M; Ospedale Pediatrico Bambino Gesù, IRCSS, Roma., Bertorello N; Presidio Infantile Regina Margherita - Città della Salute e della Scienza, Torino., Comparato C; ARNAS Civico Di Cristina Benfratelli, Palermo., Vairo U; Ospedale Giovanni XXIII, Bari., Rinelli G; Ospedale Pediatrico Bambino Gesù, IRCSS, Roma., Favilli S; Azienda Ospedaliera Meyer IRCCS, Firenze.

المصدر: Giornale italiano di cardiologia (2006) [G Ital Cardiol (Rome)] 2024 Jun; Vol. 25 (6), pp. 453-463.

نوع المنشور: Journal Article; Practice Guideline; English Abstract

بيانات الدورية: Publisher: Il Pensiero Scientifico Editore Country of Publication: Italy NLM ID: 101263411 Publication Model: Print Cited Medium: Internet ISSN: 1972-6481 (Electronic) Linking ISSN: 18276806 NLM ISO Abbreviation: G Ital Cardiol (Rome) Subsets: MEDLINE

مواضيع طبية MeSH: Cardiotoxicity*/prevention & control , Cardiotoxicity*/etiology , Neoplasms*/drug therapy , Antineoplastic Agents*/adverse effects , Antineoplastic Agents*/administration & dosage, Humans ; Child ; Italy ; Cardiovascular Diseases/prevention & control ; Cardiology ; Follow-Up Studies ; Heart Diseases/prevention & control ; Heart Diseases/chemically induced ; Heart Diseases/diagnosis ; Societies, Medical

عنوان ترانسليتريتد: Radioterapia a intensità modulata con boost simultaneo più cetuximab in pazienti con carcinoma a cellule squamose in stadio localmente avanzato del distretto testa collo: è fattibile nella pratica clinica quotidiana?

المؤلفون: Chillari F; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Parisi S; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Ferrantelli G; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Carrubba C; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Santacaterina A; Uosd Radioterapia, Ospedale Papardo, Messina., Critelli P; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Sciacca M; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Venuti V; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Lillo S; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Cacciola A; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina., Iatì G; UO Radioterapia, Azienda ospedaliero-universitaria 'G. Martino', Messina., Pontoriero A; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina - UO Radioterapia, Azienda ospedaliero-universitaria 'G. Martino', Messina., Platania A; Uosd Radioterapia, Ospedale Papardo, Messina., Delia P; UO Radioterapia, Azienda ospedaliero-universitaria 'G. Martino', Messina., Tombolini V; UO Radioterapia, Policlinico Umberto I, 'Sapienza' Università di Roma., De Felice F; UO Radioterapia, Policlinico Umberto I, 'Sapienza' Università di Roma., Musio D; UO Radioterapia oncologica, Ospedale 'Vito Fazzi', Lecce., Spatola C; UO Radioterapia oncologica, Aou Policlinico 'G. Rodolico-San Marco' Catania., Brogna A; Uoc Fisica sanitaria, Azienda ospedaliero-universitaria 'G. Martino', Messina., Pergolizzi S; Dipartimento di Scienze biomediche e odontoiatriche e delle immagini morfologiche e funzionali, Università di Messina - UO Radioterapia, Azienda ospedaliero-universitaria 'G. Martino', Messina.

المصدر: Recenti progressi in medicina [Recenti Prog Med] 2024 May; Vol. 115 (5), pp. 1e-6e.

نوع المنشور: Journal Article; Multicenter Study; English Abstract

بيانات الدورية: Publisher: Il Pensiero Scientifico Editore Country of Publication: Italy NLM ID: 0401271 Publication Model: Print Cited Medium: Internet ISSN: 2038-1840 (Electronic) Linking ISSN: 00341193 NLM ISO Abbreviation: Recenti Prog Med Subsets: MEDLINE

مواضيع طبية MeSH: Cetuximab*/administration & dosage , Head and Neck Neoplasms*/radiotherapy , Head and Neck Neoplasms*/pathology , Head and Neck Neoplasms*/therapy , Head and Neck Neoplasms*/drug therapy , Squamous Cell Carcinoma of Head and Neck*/radiotherapy , Squamous Cell Carcinoma of Head and Neck*/therapy , Squamous Cell Carcinoma of Head and Neck*/drug therapy , Squamous Cell Carcinoma of Head and Neck*/pathology , Chemoradiotherapy*/methods , Antineoplastic Agents, Immunological*/administration & dosage , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Italy ; Survival Rate ; Adult ; Treatment Outcome ; Neoplasm Staging ; Aged, 80 and over ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/therapy ; Carcinoma, Squamous Cell/radiotherapy ; Carcinoma, Squamous Cell/drug therapy ; Retrospective Studies

المؤلفون: Germani MM; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa., Vetere G; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa., Santamaria F; Department of Experimental Medicine, Sapienza University of Rome, Rome., Intini R; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua., Ghelardi F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan., Bensi M; Medical Oncology Unit, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome; Medical Oncology Unit, Università Cattolica del Sacro Cuore, Rome., Boccaccino A; Oncology Unit, Ravenna Hospital, AUSL Romagna, Ravenna., Minelli A; Department of Medical Oncology, University Campus Bio-Medico, Rome., Carullo M; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa., Ciracì P; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa., Passardi A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola., Santucci S; Oncology Unit, Ravenna Hospital, AUSL Romagna, Ravenna., Giampieri R; Oncologia Clinica, Dipartimento Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Torrette di Ancona, Ancona; Oncologia Clinica, Azienda Ospedaliero-Universitaria delle Marche, Ancona., Persano M; Medical Oncology, University Hospital of Cagliari, Cagliari; Medical Oncology, University of Cagliari, Cagliari., Fenocchio E; Department of Medical Oncology, University of Turin Medical School, Candiolo Cancer Institute, FPO, IRCCS, Candiolo, Turin., Puccini A; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Rozzano, Milan, Italy., Lonardi S; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua., Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan., Salvatore L; Medical Oncology Unit, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome; Medical Oncology Unit, Università Cattolica del Sacro Cuore, Rome., Cremolini C; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa. Electronic address: chiaracremolini@gmail.com.

المصدر: ESMO open [ESMO Open] 2024 Apr; Vol. 9 (4), pp. 102996. Date of Electronic Publication: 2024 Apr 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Cetuximab*/therapeutic use , Cetuximab*/pharmacology , Proto-Oncogene Proteins B-raf*/genetics , Carbamates*/therapeutic use , Carbamates*/pharmacology , Sulfonamides*/therapeutic use , Sulfonamides*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Mutation*, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Disease Progression ; Progression-Free Survival ; Adult ; Aged, 80 and over ; Neoplasm Metastasis ; Italy

المؤلفون: Pinto A; Department of Hematology and Developmental Therapeutics, Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS, Naples, Italy., Ladetto M; Hematology, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Martelli M; Department of Translational and Precision Medicine, Sapienza University Rome, Rome, Italy., Visco C; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy., Zaja F; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Guardalben E; Eli Lilly Italy S.p.A., Medical Affairs, Sesto Fiorentino, Italy., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.

المصدر: Hematological oncology [Hematol Oncol] 2024 Jan; Vol. 42 (1), pp. e3246.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell*/drug therapy , Lymphoma, Mantle-Cell*/pathology , Antineoplastic Agents*/therapeutic use, Adult ; Humans ; Tyrosine Kinase Inhibitors ; Agammaglobulinaemia Tyrosine Kinase ; Italy ; Protein Kinase Inhibitors/adverse effects

المؤلفون: Aapro M; Genolier Cancer Centre, Clinique de Genolier, Genolier, Switzerland., Scotté F; Interdisciplinary Cancer Course Department, Gustave Roussy Cancer Center, Villejuif, France., Escobar Y; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Celio L; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Berman R; The Christie NHS Foundation Trust, Manchester, United Kingdom., Franceschetti A; Ipsos Healthcare, London, United Kingdom., Bell D; Ipsos Healthcare, Mahwah, New Jersey, USA., Jordan K; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.

المصدر: The oncologist [Oncologist] 2021 Jun; Vol. 26 (6), pp. e1073-e1082. Date of Electronic Publication: 2021 Mar 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Antiemetics*/therapeutic use , Antineoplastic Agents*/adverse effects, Antibiotics, Antineoplastic/therapeutic use ; Europe ; France ; Germany ; Guideline Adherence ; Humans ; Italy ; Nausea/chemically induced ; Nausea/drug therapy ; Nausea/prevention & control ; Spain ; Vomiting/chemically induced ; Vomiting/drug therapy ; Vomiting/prevention & control

المؤلفون: Petrella A; Italian Medicines Agency, Rome, Italy., Fortinguerra F; Italian Medicines Agency, Rome, Italy., Cangini A; Italian Medicines Agency, Rome, Italy., Pierantozzi A; Italian Medicines Agency, Rome, Italy., Trotta F; Italian Medicines Agency, Rome, Italy.

المصدر: Frontiers in public health [Front Public Health] 2023 Oct 10; Vol. 11, pp. 1211208. Date of Electronic Publication: 2023 Oct 10 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents* , Drugs, Essential*/therapeutic use, World Health Organization ; Health Expenditures ; Europe ; Italy

المؤلفون: Valsecchi AA; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy., Fusco V; Oncology Unit, Department of Medicine Translational Medicine Unit, Department of Integration, Research and Innovation, SS Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy., Di Maio M; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy., Santini D; UOC Oncologia A, Policlinico Umberto 1, La Sapienza Università, Roma, Italy., Tucci M; Department of Medical Oncology, Cardinal Massaia Hospital, Asti, Italy., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori, Dino Amadori, Meldola, Italy., Dionisio R; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy., Vignani F; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy., Cinieri S; Medical Oncology Unit, Ospedale di Summa A. Perrino, Brindisi, Italy.

المصدر: Tumori [Tumori] 2024 Jun; Vol. 110 (3), pp. 174-185. Date of Electronic Publication: 2024 Mar 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-2529 (Electronic) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/drug therapy , Breast Neoplasms*/drug therapy, Humans ; Male ; Surveys and Questionnaires ; Female ; Osteoporosis/chemically induced ; Osteoporosis/epidemiology ; Antineoplastic Agents, Hormonal/adverse effects ; Antineoplastic Agents, Hormonal/therapeutic use ; Bone Density Conservation Agents/therapeutic use ; Bone Density Conservation Agents/adverse effects ; Italy/epidemiology ; Quality of Life ; Middle Aged ; Bone Density/drug effects ; Absorptiometry, Photon

المؤلفون: Tuninetti V; Department of Oncology, University of Turin, Medical Oncology, Ordine Mauriziano Hospital, Italy. Electronic address: dr.ssatuninettivalentina@gmail.com., Virano E; Department of Oncology, University of Turin, 10124 Turin, Italy., Salutari V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Ricotti A; Clinical Trial, Ordine Mauriziano Hospital, 10128 Turin, Italy., Pisano C; Dipartimento Uro-Ginecologico, Istituto Nazionale Tumori di Napoli Fondazione G Pascale IRCCS, Naples, Italy., Ducceschi M; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Turitto G; Division of Oncology, AORN 'Sant' Anna e San Sebastiano', Caserta, Italy., Scandurra G; Medical Oncology Unit, Cannizzaro Hospital, Catania, Italy., Petrella MC; Oncologia Medica Ginecologica, Azienda Universitaria Ospedaliera Careggi, Firenze, Italy., Forestieri V; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy., Rizzetto M; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy., Mammoliti S; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Artioli G; Ulss2 Oncologia Medica Marca Trevigiana, Treviso, Italy., Cioffi R; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy., Borsotti L; Clinical Trial, Ordine Mauriziano Hospital, 10128 Turin, Italy., Bellero M; SC Farmacia Ospedaliera, Ordine Mauriziano Hospital, 10028 Turin, Italy., Rognone C; Department of Oncology, University of Turin, Medical Oncology, Ordine Mauriziano Hospital, Italy., Carbone V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Ferrandina G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Mantiero M; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Azzolina C; SC Direzione Sanitaria, Ordine Mauriziano Hospital, 10028 Turin, Italy., Geninatti E; Department of Oncology, University of Turin, Medical Oncology, Ordine Mauriziano Hospital, Italy., Pignata S; Dipartimento Uro-Ginecologico, Istituto Nazionale Tumori di Napoli Fondazione G Pascale IRCCS, Naples, Italy., Valabrega G; Department of Oncology, University of Turin, Medical Oncology, Ordine Mauriziano Hospital, Italy.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 203, pp. 114039. Date of Electronic Publication: 2024 Mar 30.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/drug therapy , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects, Humans ; Female ; Middle Aged ; Italy ; Aged ; Adult ; Retrospective Studies ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Agents, Immunological/adverse effects ; Aged, 80 and over ; Progression-Free Survival